Skip to main content
Advertisement

Main menu

  • Home
  • Content
    • Current Issue
    • Accepted Manuscripts
    • Article Preview
    • Past Issue Archive
    • Video Articles
    • AJNR Case Collection
    • Case of the Week Archive
    • Case of the Month Archive
    • Classic Case Archive
  • Special Collections
    • AJNR Awards
    • Low-Field MRI
    • Alzheimer Disease
    • ASNR Foundation Special Collection
    • Photon-Counting CT
    • View All
  • Multimedia
    • AJNR Podcasts
    • AJNR SCANtastic
    • Trainee Corner
    • MRI Safety Corner
    • Imaging Protocols
  • For Authors
    • Submit a Manuscript
    • Submit a Video Article
    • Submit an eLetter to the Editor/Response
    • Manuscript Submission Guidelines
    • Statistical Tips
    • Fast Publishing of Accepted Manuscripts
    • Graphical Abstract Preparation
    • Imaging Protocol Submission
    • Author Policies
  • About Us
    • About AJNR
    • Editorial Board
    • Editorial Board Alumni
  • More
    • Become a Reviewer/Academy of Reviewers
    • Subscribers
    • Permissions
    • Alerts
    • Feedback
    • Advertisers
    • ASNR Home

User menu

  • Alerts
  • Log in

Search

  • Advanced search
American Journal of Neuroradiology
American Journal of Neuroradiology

American Journal of Neuroradiology

ASHNR American Society of Functional Neuroradiology ASHNR American Society of Pediatric Neuroradiology ASSR
  • Alerts
  • Log in

Advanced Search

  • Home
  • Content
    • Current Issue
    • Accepted Manuscripts
    • Article Preview
    • Past Issue Archive
    • Video Articles
    • AJNR Case Collection
    • Case of the Week Archive
    • Case of the Month Archive
    • Classic Case Archive
  • Special Collections
    • AJNR Awards
    • Low-Field MRI
    • Alzheimer Disease
    • ASNR Foundation Special Collection
    • Photon-Counting CT
    • View All
  • Multimedia
    • AJNR Podcasts
    • AJNR SCANtastic
    • Trainee Corner
    • MRI Safety Corner
    • Imaging Protocols
  • For Authors
    • Submit a Manuscript
    • Submit a Video Article
    • Submit an eLetter to the Editor/Response
    • Manuscript Submission Guidelines
    • Statistical Tips
    • Fast Publishing of Accepted Manuscripts
    • Graphical Abstract Preparation
    • Imaging Protocol Submission
    • Author Policies
  • About Us
    • About AJNR
    • Editorial Board
    • Editorial Board Alumni
  • More
    • Become a Reviewer/Academy of Reviewers
    • Subscribers
    • Permissions
    • Alerts
    • Feedback
    • Advertisers
    • ASNR Home
  • Follow AJNR on Twitter
  • Visit AJNR on Facebook
  • Follow AJNR on Instagram
  • Join AJNR on LinkedIn
  • RSS Feeds

AJNR Awards, New Junior Editors, and more. Read the latest AJNR updates

Research ArticleNEUROINTERVENTION

Evaluation of Conditions for the Development of Cryogenic Spinal Cord Injury Using a Canine Model: An Experimental Study on the Safety of Cryoablation for Metastatic Spinal Tumors

Motoya Kobayashi, Satoshi Kato, Satoru Demura, Noriaki Yokogawa, Akira Yokka, Yusuke Nakade, Ryohei Annen, Toshifumi Gabata and Hiroyuki Tsuchiya
American Journal of Neuroradiology March 2024, DOI: https://doi.org/10.3174/ajnr.A8151
Motoya Kobayashi
aFrom the Department of Orthopedic Surgery (M.K., S.K., S.D., N.Y., R.A., H.T.), Graduate School of Medical Sciences, Kanazawa University, Kanazawa, Ishikawa, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Satoshi Kato
aFrom the Department of Orthopedic Surgery (M.K., S.K., S.D., N.Y., R.A., H.T.), Graduate School of Medical Sciences, Kanazawa University, Kanazawa, Ishikawa, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Satoshi Kato
Satoru Demura
aFrom the Department of Orthopedic Surgery (M.K., S.K., S.D., N.Y., R.A., H.T.), Graduate School of Medical Sciences, Kanazawa University, Kanazawa, Ishikawa, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Satoru Demura
Noriaki Yokogawa
aFrom the Department of Orthopedic Surgery (M.K., S.K., S.D., N.Y., R.A., H.T.), Graduate School of Medical Sciences, Kanazawa University, Kanazawa, Ishikawa, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Noriaki Yokogawa
Akira Yokka
bDepartment of Radiology (A.Y., T.G.), Graduate School of Medical Sciences, Kanazawa University, Kanazawa, Ishikawa, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Akira Yokka
Yusuke Nakade
cDepartment of Clinical Laboratory (Y.N.), Kanazawa University Hospital, Kanazawa, Ishikawa, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Yusuke Nakade
Ryohei Annen
aFrom the Department of Orthopedic Surgery (M.K., S.K., S.D., N.Y., R.A., H.T.), Graduate School of Medical Sciences, Kanazawa University, Kanazawa, Ishikawa, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Ryohei Annen
Toshifumi Gabata
bDepartment of Radiology (A.Y., T.G.), Graduate School of Medical Sciences, Kanazawa University, Kanazawa, Ishikawa, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hiroyuki Tsuchiya
aFrom the Department of Orthopedic Surgery (M.K., S.K., S.D., N.Y., R.A., H.T.), Graduate School of Medical Sciences, Kanazawa University, Kanazawa, Ishikawa, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Supplemental
  • Info & Metrics
  • Responses
  • References
  • PDF
Loading

Abstract

BACKGROUND AND PURPOSE: Although the application of cryoablation to metastatic spinal tumors has been attempted, spinal cryoablation has the unique complication of cryogenic spinal cord injury. This study aimed to elucidate the conditions for the development of cryogenic spinal cord injury.

MATERIALS AND METHODS: Fifteen canines were used in this study. A metal probe was inserted into the 13th thoracic vertebral body. Cryoablation was performed for 10 minutes by freezing the probe in liquid nitrogen. The control canine underwent probe insertion only. Spinal cord monitoring, epidural temperature measurement, motor function assessment, and pathologic examination of the spinal cord were performed.

RESULTS: During the 10 minutes of cryoablation, the epidural temperature decreased and reached the lowest epidural temperature (LET) at the end of cryoablation. The LETs (degrees celsius [°C]) of each canine were −37, −30, −27, −8, −3, −2, 0, 1, 4, 8, 16, 18, 20, and 25, respectively. As the epidural temperature decreased, waveform amplitudes also decreased. At the end of cryoablation (10 minutes after the start of cryoablation), abnormal waves were observed in 92.9% (13/14) of canines. With epidural rewarming, the amplitude of the waveforms tended to recover. After epidural rewarming (2 hours after the start of cryoablation), abnormal waves were observed in 28.6% (4/14) of canines. The LETs (°C) of the canines with abnormal waves after epidural rewarming were −37, −30, −27, and −8. None of the canines with normal waves after epidural rewarming had any motor impairment. In contrast, all canines with remaining abnormal waves after epidural rewarming had motor impairment. In the pathologic assessment, cryogenic changes were found in canines with LETs (°C) of −37 −30, −27, −8, 0, and 1.

CONCLUSIONS: This study showed that 10-minute spinal cryoablation with LETs (°C) of −37, −30, −27, −8, 0, and 1 caused cryogenic spinal cord injury. There was no evidence of cryogenic spinal cord injury in canines with LET of ≥4°C. The epidural temperature threshold for cryogenic spinal cord injury is between 1 and 4°C, suggesting that the epidural temperature should be maintained above at least 4°C to prevent cryogenic spinal cord injury.

ABBREVIATIONS:

CMAP
compound muscle action potential
LET
lowest epidural temperature
SCEP
spinal cord–evoked potential

Metastatic spinal tumors can significantly compromise a patient’s quality of life because they can cause severe pain, pathologic vertebral fractures, and spinal cord compression.1 Therefore, local control of metastatic spinal lesions is essential to maintain a patient’s quality of life, particularly in patients with oligometastatic disease, which has a better prognosis.

Currently, the standard treatments for metastatic spinal tumors are based on surgical and radiation therapy. Surgical treatment is an effective procedure that can remove or reduce metastatic spinal lesions and provide spinal stability with instrumentation.2 However, surgery is usually not performed in patients with extensive metastatic disease burden and patients with poor functional status because of surgical invasiveness and the risk of developing complications.3 Therefore, the current mainstay of treatment for metastatic spinal tumors is radiation therapy. In addition, the emerging technique of stereotactic body radiation therapy is reported to be effective even for radioresistant tumors.

Recently, cryoablation using extremely cold conditions to destroy tumor cells has been widely used in tumor treatment for various organs. Cryoablation is increasingly being performed in musculoskeletal metastases and has been reported to provide sustainable local control.4,5 The advantages of cryoablation include direct visualization of the ablation zone, decreased periprocedural pain, and the ability to use multiple probes in variable configurations to create tailored ablation zones.6 Moreover, the efficacy of cryoablation has been confirmed in radiation therapy–resistant tumors such as renal cancer.7 In clinical practice, cryoablation has been used for metastatic spinal tumors.8

However, cryoablation of the spine may result in cryogenic spinal cord injury, a serious complication occurring when cooling causes irreversible damage to the spinal cord.9 Moreover, the conditions for developing cryogenic spinal cord injury remain unclear, so there are limited indications for the use of cryoablation in metastatic spinal tumors. To establish the safety of spinal cryoablation, it is important to identify the conditions for developing cryogenic spinal cord injury. This study aimed to determine the threshold epidural temperature for developing cryogenic spinal cord injury using a canine spinal cryoablation model.

MATERIALS AND METHODS

Experiments were performed on 15 canines (female Beagles) between 9 and 10 kg and 80 and 90 cm in length. All canines were acclimatized under the same conditions at the Institute for Animal Experiments, where they were housed individually in metal cages and provided with food and water ad libitum.

Anesthetic Technique

After the administration of medetomidine (30 µg/kg) and midazolam (0.3 mg/kg) into the paravertebral muscles, a catheter was inserted into the radial vein for drug administration and fluid replacement. The canines were intubated and artificially ventilated with 50% nitrous oxide and 50% oxygen. They were placed in the prone position on an operating table under IV anesthesia with propofol (0.2 mg/kg/min). Muscle relaxants were not used. A cannula (2.0-mm diameter) was inserted into the right femoral artery for repeat blood sampling and continuous blood pressure monitoring. Body temperature was maintained between 36°C and 37°C using a heating pad as necessary and monitored with a rectal temperature probe. Arterial blood gases were measured at 90-minute intervals. The metabolic and respiratory acid-base balance was controlled with supplemental IV NaHCO3 to maintain a pH of approximately 7.40. PaO2 was maintained above 100 mm Hg, and PaCO2 was maintained between 30 and 45 mm Hg by adjusting the respiratory volume. Concentrations of nitrous oxide and oxygen were constant throughout the procedure. Painful stimulation did not cause any increase in blood pressure during steady-state anesthesia. Systemic blood pressure was maintained between 90 and 120 mm Hg for all procedures. In cases with a hypotensive trend, the infusion solution was increased or the propofol flow volume was slightly decreased.

Freezing Device

A freezing device was created for our experiment on the basis of a previous report.10 A 10-mL disposable syringe was incorporated into a 20-mL syringe to create a layer of air and prevent heat conduction from the syringe surface. A metal wire was placed at the tip of the syringe to form the cryoprobe. The metal wire tip was rapidly cooled via thermal conduction by injecting liquid nitrogen into the device (Fig 1A).

FIG 1.
  • Download figure
  • Open in new tab
  • Download powerpoint
FIG 1.

A, Details of cryoablation and thermal monitoring. B, Details of spinal cord monitoring.

Surgical and Cryoablation Procedures

After exposing the laminae from T11 to L2 through a posterior midline longitudinal incision, laminectomy at T13 and resection of the left proximal 13th rib were performed. After we exposed the left lateral aspect of the T13 vertebral body, a hole for the insertion of a cryoprobe was made using a 3-mm steel bar and a pedicle probe. A cryoprobe was inserted into the T13 vertebra, and 10-minute cryoablation was performed (Fig 1A). The intensity of cryoablation varied for each canine by changing the diameter and material of the metal probe (diameter range of probe: 1.2–2.0 mm; material of probe: copper or iron). An increase in probe size led to higher freezing intensity. Furthermore, changing the probe material from iron to copper amplified the freezing intensity due to differences in thermal conductivity (Online Supplemental Data). The control canine underwent probe insertion as a sham operation. In this procedure, 1 cycle of 10 minutes of cooling and passive thawing was performed with epidural temperature measurement and spinal cord monitoring performed until 120 minutes after the start of cryoablation. Ablated vertebrae were evaluated by a CT apparatus for small experimental animals (Model LaTheta LCT-200; Hitachi-Aloka) to confirm that the probe hole was in the appropriate position 7 days after the cryoablation procedure.

Thermal Monitoring

Two spatula-type thermocouples (MF-SP-K; AS ONE; range: −50 degrees celsius [°C] to 200°C) were inserted into the ventral epidural space of T13 on the same plane as the cryoprobe, measuring the temperature of the bilateral ventral epidural space. In addition, a sheath-type thermocouple (S1K05 × 300–2; TOHO ELECTRONICS; range: −50°C to 200°C) was attached to the tip of the cryoprobe to monitor the intravertebral temperature (Fig 1A). Each temperature was recorded every 10 seconds until 2 hours after the start of cryoablation and recorded using a data logger (GL240-SD; GRAPHTEC).

Compound Muscle Action Potentials and Spinal Cord–Evoked Potentials

Spinal cord function was evaluated using compound muscle action potentials (CMAPs)11,12 and spinal cord–evoked potentials (SCEPs)11,13 produced by spinal cord stimulation (Fig 1B).

CMAPs were recorded from the bilateral soleus muscles with each pair of needle electrodes (NE-110B; Nihon Kohden) using the tendon-belly method after spinal cord stimulation.14 The electrodes for stimulation consisted of 18-ga tubes with 2 fine platinum coil terminals covered with polyethylene insulation (USY-100-2PMC; Unique Medical). The stimulating electrode was placed on the posterior midline of the dura mater at the level of T9, introduced from the laminectomy site at T13. The stimulus condition had a rectangular waveform, a pulse duration of 0.5ms, an interstimulus interval of 2.0 ms, and a train of 5 pulses per stimulation at 1 Hz to evoke muscle action potentials. The stimulation intensity ranged from 2 to 3 mA and was set to 10% above the level that elicited the maximal amplitude. A band-pass filter was selected at 10–3000 Hz, and the mean summation was 10. A Neuropack ∑EMG-SYSTEM (MEB-5504; Nihon Kohden) was used to record the signals. CMAPs were recorded before cryoablation (control) and at 2.5, 5, 7.5, 10, 30, 60, and 120 minutes after the start of cryoablation. Amplitude was measured between the maximum positive and negative peaks. Decreases of >70% of the control CMAP amplitudes were considered abnormal.15 The CMAP reflects the activity of the corticospinal tract (mainly the lateral column) and the anterior horn cells of the spinal gray matter.

In the SCEP study, the stimulating electrode (USY-100-2PMC) was placed on the posterior midline of the dura mater at the level of T9, introduced from the laminectomy site at T13. A recording electrode (USY-100-2PMC) was placed on the posterior midline of the dura mater at the level of L3, introduced from the laminectomy site at T13. The spinal cord stimulation used a rectangular waveform for 0.2-ms duration at 5 Hz. Furthermore, stimulation intensity was set at a supramaximal strength. The band-pass filter was set at 10–3000 Hz, and the mean summation at 50. A Neuropack ∑EMG-SYSTEM (MEB-5504) was used to record the signals. SCEPs were recorded before cryoablation (control) and at 2.5, 5, 7.5, 10, 30, 60, and 120 minutes after the start of cryoablation. Amplitude was measured between the maximum negative and positive peaks of the first potential. Decreases of >50% in control SCEP amplitudes were considered abnormal.13,16 The SCEP mainly reflects the combined activity of the long tract in the dorsal and lateral columns.

Postprocedural Neurologic Examination

Postprocedural neurologic function was evaluated using a modified Tarlov scale17,18 at 1 day and 1 week after the cryoablation procedure. The scale used is presented in the Table.

Pathologic Examination

Seven days after the cryoablation procedure,18,19 the canines were euthanized using an IV potassium chloride bolus. The T13 vertebra, including the spinal cord, was removed and fixed in 10% formalin. The mean length of the T13 vertebral body (maximal anterior-posterior diameter of the vertebral body), width (maximal transverse diameter of the vertebral body), and height (central height of the vertebral body) were 7.8 (SD, 0.56) mm, 15.2 (SD, 0.69) mm, and 15.3 (SD, 0.85) mm, respectively. The specimens were demineralized with ethylenediaminetetraacetic acid and stained with H&E for pathologic evaluation. Observations were performed using a microscope (BZ-9000; KEYENCE).

RESULTS

During the 10 minutes of cryoablation, the epidural temperature continued to decrease until the end of cryoablation. Overall, the left epidural measurement point had a lower temperature curve than the right. The left epidural temperature at the end of cryoablation (10 minutes after the start of cryoablation) was the lowest in each experiment. The lowest epidural temperatures (LETs) (°C) of each canine were −37, −30, −27, −8, −3, −2, 0, 1, 4, 8, 16, 18, 20, and 25. The epidural temperature increased after the end of cryoablation and almost recovered within 20 minutes after the end of cryoablation in all canines (Fig 2).

FIG 2.
  • Download figure
  • Open in new tab
  • Download powerpoint
FIG 2.

Temperature curves of the representative case with the lowest epidural temperature of 4 °C (case 6).

The relationship between the amplitude of spinal cord monitoring during cryoablation and the corresponding epidural temperature is illustrated in scatterplots (Fig 3). As the epidural temperature decreased, the waveform amplitudes of spinal cord monitoring also decreased. At the end of cryoablation, abnormal waves in CMAPs and SCEPs were observed in 85.7% (12/14) and 78.6% (11/14) of the canines, respectively.

FIG 3.
  • Download figure
  • Open in new tab
  • Download powerpoint
FIG 3.

A, Scatterplots illustrate the relationship between the left and right CMAPs at 2.5, 5, 7.5, and 10 minutes after the start of cryoablation and the corresponding epidural temperatures. B, Scatterplots illustrate the relationship between the SCEPs at 2.5, 5, 7.5, and 10 minutes after the start of cryoablation and an average of the corresponding left and right epidural temperatures.

Thirteen canines had abnormal waveforms in either the CMAPs or SCEPs at the end of cryoablation; however, the amplitude of the waveforms recovered in 9 canines with the rewarming of the epidural temperature (Fig 4A). After epidural rewarming (2 hours after the start of cryoablation), abnormal waves of CMAPs and SCEPs were observed in 28.6% (4/14) and 21.4% (3/14) of the canines, respectively. In cases with LETs of −37°C, −30°C, and −27°C, abnormal waves of CMAPs and SCEPs remained after epidural rewarming. In the canine with an LET of −8°C, abnormal waves of CMAPs remained after epidural rewarming (Fig 4B).

FIG 4.
  • Download figure
  • Open in new tab
  • Download powerpoint
FIG 4.

Change of the CMAP and SCEP waveform in representative cases with the lowest epidural temperature of 18 °C (case 3) (A) and –8 °C (case 11) (B). A, The CMAP and SCEP waveforms decreased as the epidural temperature dropped. However, the waveforms recovered with rewarming of the epidural temperature. B, The CMAP and SCEP waveforms decreased as the epidural temperature dropped. The waveform of the CMAP did not completely recover after rewarming of the epidural temperature.

All canines with normal waves on spinal cord monitoring after epidural rewarming had no hindlimb motor impairment with grade V on the modified Tarlov scale on day 1 and week 1 after the procedure. In contrast, all canines that showed abnormal waves in spinal cord monitoring after epidural rewarming had grade III or lower hindlimb motor impairment on the modified Tarlov scale on day 1 and week 1 after the procedure.

During the pathologic assessment of the spinal cord, cryogenic changes were detected in the canines with LETs (°C) of −37, −30, −27, −8, 0, and 1. In the lesion of cryogenic change, there were characteristic findings of acute spinal cord injury, including the proliferation of glial cells, neuronal vacuolation (spongiosis), and dilated myelin sheaths containing hypereosinophilic swollen axons (spheroids) (Fig 5).

FIG 5.
  • Download figure
  • Open in new tab
  • Download powerpoint
FIG 5.

The pathologic findings of the spinal cord in H&E staining. A, The pathologic specimen of the spinal cord in the representative case with the lowest epidural temperature of −8 °C (case 11) illustrates the cryogenic change in the left lateral and anterior columns (2× magnification). B, In lesions of cryogenic change, there is the proliferation of glial cells, neuronal vacuolation (spongiosis), and dilated myelin sheaths that contain hypereosinophilic swollen axons (spheroids) (60× magnification). C and D, The pathologic specimens of the spinal cord in cases 7 (C) and 8 (D). In these 2 cases with the lowest epidural temperatures of 1 °C (case 7) and 0 °C (case 8), the pathologic evaluation shows cryogenic spinal cord injuries, though spinal cord monitoring after epidural rewarming and the postprocedural motor function were normal. The specimens of the spinal cord in cases 7 (C) and 8 (D) illustrate the cryogenic changes in the left lateral and anterior columns (2× magnification).

A summary of the results, including intravertebral and epidural temperatures at the end of cryoablation, amplitude change of spinal cord monitoring, postprocedural modified Tarlov scale, and pathologic findings, are described in the Online Supplemental Data.

The sensitivity and specificity for detecting pathologic spinal cord injury in spinal cord monitoring combined with CMAPs and SCEPs during cryoablation were 100% (6/6) and 12.5% (1/8), respectively. After epidural rewarming, the sensitivity and specificity in spinal cord monitoring for detecting pathologic spinal cord injury were 66.7% (4/6) and 100% (8/8), respectively. The sensitivity and specificity of detecting postprocedural motor impairment in spinal cord monitoring after epidural rewarming were 100% (4/4) and 100% (10/10), respectively.

DISCUSSION

This study was the first experimental study to focus on elucidating the conditions under which cryogenic spinal cord injury develops. This study included conventional assessments, such as an observation of motor function and pathologic evaluation of the spinal cord, as well as an electrophysiologic assessment of the spinal cord. The effects of cryoablation on the spinal cord were investigated in detail by real-time monitoring of the spinal cord function.

To date, 2 experimental studies have been conducted on the safety of spinal cryoablation. Wallace et al20 examined the thermal protective capacity of the vertebral cortex and the accuracy of MR imaging for monitoring the ablation area using a sheep model. de Freitas et al19 performed cryoablation of porcine vertebrae and verified the feasibility of cryoablation of the spine. However, these 2 studies did not examine the conditions under which cryogenic spinal cord injury develops.

In the current study, findings of cryogenic spinal cord injury were observed in all cases with an LET of −8°C or lower. These results may be associated with extracellular ice formation. Water in the extracellular space crystallizes as the temperature drops to approximately −7°C.21 The extracellular fluid becomes hypertonic because of extracellular ice formation, causing cell dehydration and desiccation, which results in cell death. An experimental study using a rat model showed extensive axonal damage with loosening and edematous changes in interstitial tissue in the spinal cord after freezing at −8°C for 15 minutes,22 supporting our hypothesis that the withdrawal of water because of extracellular ice formation is associated with cryogenic spinal cord injury. Hence, spinal cryoablation with an LET of −8°C or lower, with extracellular ice crystal formation, may have a considerable risk of cryogenic spinal cord injury.

In all cases with an LET of −3°C or higher, intraprocedural spinal cord monitoring waveforms recovered after epidural rewarming, and the postprocedural motor function was normal. However, the pathologic evaluation revealed cryogenic spinal cord injury in 2 cases with LETs of 0°C and 1°C (Fig 5C, -D). In these 2 cases, cryogenic spinal cord injury was observed in a temperature range in which extracellular ice formation did not occur.

There is a similar phenomenon in the peripheral nerves called nonfreezing cold nerve injury, in which cryogenic nerve injury develops at a temperature above the freezing point. A rat model study demonstrated pathologic cryogenic nerve injury and an irreversible reduction in nerve blood flow after local cooling of the sciatic nerve for 3 hours at 1°C to 5°C, showing that ischemia plays a principal role in the nonfreezing cold nerve injury.23 Moreover, the association between cooling with near-freezing temperatures and ischemia has been reported in the spinal cord. A canine experimental model reported that spinal cord blood flow decreased to 50% of the normothermic values during the cooling of the posterior dura mater to 3°C.24 Considering these results, cooling to near-freezing temperatures may pose a risk of spinal cord injury including spinal cord ischemia, even if it does not reach the freezing range of extracellular fluid.

There were no cryogenic spinal cord injury findings in all cases with LETs of 4°C or higher. This finding was consistent with the results of a canine experimental model in which no cryogenic spinal cord injury was reported after selective spinal cord cooling at a dorsal column temperature of 5°C to 6°C for 100 minutes.25 These results show that maintaining the epidural temperature above at least 4°C prevents cryogenic spinal cord injury during cryoablation for metastatic spinal tumors.

To the best of our knowledge, this study is the first reported experiment to visualize the electrical activity of the spinal cord during cryoablation using spinal cord monitoring. The application of spinal cord monitoring for cryoablation of metastatic spinal tumors has been attempted to compensate for the disadvantage of conventional ice ball monitoring, namely that only frozen areas can be visualized.8 The findings of this study may contribute to establishing optimal protocols for spinal cord monitoring during cryoablation of metastatic spinal tumors.

The current study showed that the sensitivity for detecting cryogenic spinal cord injury in spinal cord monitoring combined with CMAPs and SCEPs during cryoablation was relatively high, 100% (6/6), and there were no false-negatives. Therefore, if the normal waveform of spinal cord monitoring is confirmed during cryoablation, the development of cryogenic spinal cord injury can be excluded, providing useful intraoperative information. However, the specificity for detecting cryogenic spinal cord injury in spinal cord monitoring during cryoablation was low at 12.5% (1/8), because spinal cord monitoring during cryoablation shows transient waveform reduction because of cooling. Hence, setting a lower threshold for abnormal waveforms should be considered when using spinal cord monitoring to reduce the rate of false-positives. In the present study, if even the slightest waveform of CMAP was observed during cryoablation, the ventral epidural temperature was confirmed to be at least 7.1°C, with a low risk of developing cryogenic spinal cord injury (Fig 3A). Therefore, during cryoablation, defining waveform disappearance as an abnormality in CMAPs may be practical.

In contrast, after epidural rewarming, spinal cord monitoring showed better diagnostic accuracy for detecting cryogenic spinal cord injury (sensitivity: 66.7% [4/6]; specificity: 100% [8/8]). However, 2 false-negative cases (cases 7 and 8) resulted in a slightly low sensitivity. In both false-negative cases, most areas of cryogenic injury were located in the anterolateral part of the spinal cord (Fig 5C, -D), possibly making detecting the cryogenic damage difficult in spinal cord monitoring combined with CMAPs (which mainly reflect electrical activity in the lateral column of the spinal cord) and SCEPs (which mainly reflect electrical activity in the lateral and posterior column of the spinal cord). Additionally, as shown in case 11 in which the waveform recovered after epidural rewarming in SCEPs but not CMAPs, SCEPs are considered to have a lower LET cutoff value for waveform recovery after epidural rewarming than CMAPs. This finding may be because CMAPs are generally the most sensitive method among the various spinal cord monitoring procedures.26 Another possible reason may be that SCEPs mainly reflect electrical activity in the lateral and posterior columns of the spinal cord, making it difficult to detect cryogenic damage in the anterior part of the spinal cord accurately, compared with CMAPs.

Notably, for detecting postprocedural motor impairment, the sensitivity and specificity in spinal cord monitoring after epidural rewarming were quite high at 100% (4/4) and 100% (10/10), respectively. Intraoperative prediction for postprocedural motor impairment is crucial because motor impairment can directly affect activities of daily living and quality of life.27 Using spinal cord monitoring would contribute to preventing postprocedural motor impairment, which is associated with great benefits in cryoablation for metastatic spinal tumors.

Although spinal cord monitoring is useful for detecting cryogenic spinal cord injury, it has the disadvantage of many false-positives at low epidural temperatures during cryoablation. Therefore, if a certain degree of epidural temperature reduction is expected, such as in cryoablation of spinal metastases surrounding the spinal cord, the combined use of epidural temperature measurement would be desirable. Previous studies have demonstrated the feasibility and safety of thermal ablation with real-time monitoring of the epidural temperature for treating spinal metastases adjacent to the spinal cord.28,29 A thermocouple in contact with the spinal cord provides continuous thermal monitoring of the surrounding spinal cord. Precise prediction of the development of spinal cord injury is possible by combining this real-time thermal monitoring with the findings on the conditions for the development of cryogenic spinal cord injury.

However, accurate placement of the thermocouple for measuring epidural temperature is challenging using a percutaneous procedure. Additionally, the preventive measure applied to avoid cryogenic spinal cord injury, such as carbon dioxide epidural injection, may interfere with the accuracy of the measurement of epidural temperature. A previous study recommended the placement of several thermocouples, because a single thermocouple may not be able to reflect the area of the largest temperature change.30 On the contrary, when cryoablation is combined with open decompression surgery for spinal metastases, thermocouples and insulation material for protecting the spinal cord can be directly placed in an appropriate epidural position because the spinal cord is exposed intraoperatively. We believe that this combined therapy can not only enhance local tumor control and functional prognosis but also improve the safety of the cryoablation procedure.

This study had several limitations. First, only 1 cycle of cooling and thawing was performed, and 2 cycles of cooling and thawing are commonly performed in clinical spinal cryoablation.8 We focused on 1 cycle of cooling and thawing in this study because in an experiment with 2 cycles, we cannot determine whether the first, second, or both cycles caused the cryogenic spinal cord injury, making it difficult to identify the accurate epidural temperature at which cryogenic spinal cord injury develops. A future study is required investigating the relationship between the cooling and thawing cycles and the conditions for the development of cryogenic spinal cord injury. Second, this study evaluated the LET but did not examine the cooling rate. The cooling rate is a factor that determines the degree of cryogenic tissue damage,31 and this should be assessed in future studies. Third, this study sample was not strictly a spinal cryoablation model. The intravertebral temperature must be below −40°C, when cryogenic tumor death occurs, to establish an accurate spinal cryoablation model.32 However, to prepare the cryoablation models with various ranges of epidural temperatures, it was necessary to include the models with intravertebral temperatures above −40°C, because creating a significant difference between the intravertebral and epidural temperatures was difficult due to the small size of the canine model in this study. Fourth, healthy vertebrae were used for this cryoablation model. The cooling distribution may be different between healthy vertebrae and tumor vertebrae due to mixed tissue with tumor and bone marrow, lytic destruction, and extraosseous extension into the canal. This limitation needs to be considered when applying the results of the current study to cases of spinal metastasis in clinical practice. Fifth, in this experiment, the lateral approach was used for probe placement because with the use of the transpedicular approach, there was a significant risk of probe deviation into the spinal canal from the canine’s thin pedicle. This experimental system was designed to focus on investigating the conditions in which the cryogenic spinal cord injury develops, and this experimental system does not directly reflect clinical spinal cryoablation in which the transpedicular approach is commonly performed.

Despite these limitations, the findings of this study on the conditions for the development of cryogenic spinal cord injury contribute to establishing suitable monitoring methods and appropriate preventive measures for cryogenic spinal cord injury.

CONCLUSIONS

This study showed that spinal cryoablation with a duration of 10 minutes and LETs (°C) of −37, −30, −27, −8, 0, and 1 caused cryogenic spinal cord injury. In contrast, there were no cryogenic spinal cord injury findings in the cases with LETs of 4°C or higher. Therefore, the epidural temperature threshold for cryogenic spinal cord injury was considered between 1°C and 4°C, suggesting that the epidural temperature should be maintained above 4°C to prevent cryogenic spinal cord injury during cryoablation for metastatic spinal tumors.

Grade
0Complete paraplegia with no hind extremity function
IMinor joint movements
IIMajor joint movements
IIIAnimal can stand
IVAnimal can walk
VAnimal can climb a 20° inclined plane

Modified Tarlov scale

Acknowledgments

We are grateful to Suga Chikazawa for her assistance with the pathologic examination. We would like to thank Yoshihiro Mozumi for technical assistance with the experiments. We are grateful to Kotoe Kobayashi for her assistance with creating the figures and to the members of the Institute for Animal Experiments for their important contributions to the experiments.

Footnotes

  • This research was supported by a Grant-in-Aid for Scientific Research, grant No. 22K09303.

  • This funder did not play any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.

  • Disclosure forms provided by the authors are available with the full text and PDF of this article at www.ajnr.org.

References

  1. 1.↵
    1. Nater A,
    2. Martin AR,
    3. Sahgal A, et al
    . Symptomatic spinal metastasis: a systematic literature review of the preoperative prognostic factors for survival, neurological, functional and quality of life in surgically treated patients and methodological recommendations for prognostic studies. PLoS One 2017;12:e0171507 doi:10.1371/journal.pone.0171507 pmid:28225772
    CrossRefPubMed
  2. 2.↵
    1. Laufer I,
    2. Rubin DG,
    3. Lis E, et al
    . The NOMS framework: approach to the treatment of spinal metastatic tumors. Oncologist 2013;18:744–51 doi:10.1634/theoncologist.2012-0293 pmid:23709750
    Abstract/FREE Full Text
  3. 3.↵
    1. Tarawneh AM,
    2. Pasku D,
    3. Quraishi NA
    . Surgical complications and re-operation rates in spinal metastases surgery: a systematic review. Eur Spine J 2021;30:2791–99 doi:10.1007/s00586-020-06647-6 pmid:33184702
    CrossRefPubMed
  4. 4.↵
    1. Callstrom MR,
    2. Charboneau JW,
    3. Goetz MP, et al
    . Image-guided ablation of painful metastatic bone tumors: a new and effective approach to a difficult problem. Skeletal Radiol 2006;35:1–15 doi:10.1007/s00256-005-0003-2 pmid:16205922
    CrossRefPubMed
  5. 5.↵
    1. Kurup AN,
    2. Morris JM,
    3. Callstrom MR
    . Ablation of musculoskeletal metastases. AJR Am J Roentgenol 2017;209:713–21 doi:10.2214/AJR.17.18527 pmid:28777648
    CrossRefPubMed
  6. 6.↵
    1. Kwak K,
    2. Yu B,
    3. Lewandowski RJ, et al
    . Recent progress in cryoablation cancer therapy and nanoparticles mediated cryoablation. Theranostics 2022;12:2175–204 doi:10.7150/thno.67530 pmid:35265206
    CrossRefPubMed
  7. 7.↵
    1. Ismail M,
    2. Nielsen TK,
    3. Lagerveld B, et al
    . Renal cryoablation: multidisciplinary, collaborative and perspective approach. Cryobiology 2018;83:90–94 doi:10.1016/j.cryobiol.2018.06.002 pmid:29890126
    CrossRefPubMed
  8. 8.↵
    1. Tomasian A,
    2. Wallace A,
    3. Northrup B, et al
    . Spine cryoablation: pain palliation and local tumor control for vertebral metastases. AJNR Am J Neuroradiol 2016;37:189–95 doi:10.3174/ajnr.A4521 pmid:26427837
    Abstract/FREE Full Text
  9. 9.↵
    1. Tan LA,
    2. Deutsch H
    . Thermal injury of thoracic spinal cord after percutaneous cryoablation of spinal tumor–when needles are more dangerous than the knife. Br J Neurosurg 2015;29:443 doi:10.3109/02688697.2014.997672 pmid:25562681
    CrossRefPubMed
  10. 10.↵
    1. Annen R,
    2. Kato S,
    3. Demura S, et al
    . Tumor-specific immunoenhancing effects after local cryoablation for metastatic bone tumor in a mouse model. Int J Mol Sci 2022;23:9445 doi:10.3390/ijms23169445 pmid:36012709
    CrossRefPubMed
  11. 11.↵
    1. Iwasaki H,
    2. Tamaki T,
    3. Yoshida M, et al
    . Efficacy and limitations of current methods of intraoperative spinal cord monitoring. J Orthop Sci 2003;8:635–42 doi:10.1007/s00776-003-0693-z pmid:14557928
    CrossRefPubMed
  12. 12.↵
    1. Machida M,
    2. Weinstein SL,
    3. Yamada T, et al
    . Monitoring of motor action potentials after stimulation of the spinal cord. J Bone Joint Surg Am 1988;70:911–18 doi:10.2106/00004623-198870060-00016 pmid:3392089
    Abstract/FREE Full Text
  13. 13.↵
    1. Tamaki T,
    2. Noguchi T,
    3. Takano H, et al
    . Spinal cord monitoring as a clinical utilization of the spinal evoked potential. Clin Orthop Relat Res 198458–64 doi:10.1097/00003086-198404000-00008 pmid:6705365
    CrossRefPubMed
  14. 14.↵
    1. Nakagawa Y,
    2. Tamaki T,
    3. Yamada H, et al
    . Discrepancy between decreases in the amplitude of compound muscle action potential and loss of motor function caused by ischemic and compressive insults to the spinal cord. J Orthop Sci 2002;7:102–10 doi:10.1007/s776-002-8430-x pmid:11819141
    CrossRefPubMed
  15. 15.↵
    1. Kobayashi S,
    2. Matsuyama Y,
    3. Shinomiya K, et al
    . A new alarm point of transcranial electrical stimulation motor evoked potentials for intraoperative spinal cord monitoring: a prospective multicenter study from the Spinal Cord Monitoring Working Group of the Japanese Society for Spine Surgery and Related Research. J Neurosurg Spine 2014;20:102–07 doi:10.3171/2013.10.SPINE12944 pmid:24236669
    CrossRefPubMed
  16. 16.↵
    1. Shinomiya K,
    2. Furuya K,
    3. Sato R, et al
    . Electrophysiologic diagnosis of cervical OPLL myelopathy using evoked spinal cord potentials. Spine (Phila Pa 1976) 1988;13:1225–33 doi:10.1097/00007632-198811000-00004 pmid:3144756
    CrossRefPubMed
  17. 17.↵
    1. Tarlov IM,
    2. Klinger H
    . Spinal cord compression studies, II: time limits for recovery after acute compression in dogs. AMA Arch Neurol Psychiatry 1954;71:271–90 pmid:13123590
    CrossRefPubMed
  18. 18.↵
    1. Kato S,
    2. Kawahara N,
    3. Tomita K, et al
    . Effects on spinal cord blood flow and neurologic function secondary to interruption of bilateral segmental arteries which supply the artery of Adamkiewicz: an experimental study using a dog model. Spine (Phila Pa 1976) 2008;33:1533–41 doi:10.1097/BRS.0b013e318178e5af pmid:18520634
    CrossRefPubMed
  19. 19.↵
    1. de Freitas RM,
    2. Andrade CS,
    3. Caldas JG, et al
    . Image-guided cryoablation of the spine in a swine model: clinical, radiological, and pathological findings with light and electron microscopy. Cardiovasc Intervent Radiol 2015;38:1261–70 doi:10.1007/s00270-014-1043-6 pmid:25552399
    CrossRefPubMed
  20. 20.↵
    1. Wallace AN,
    2. Hillen TJ,
    3. Friedman MV, et al
    . Percutaneous spinal ablation in a sheep model: protective capacity of an intact cortex, correlation of ablation parameters with ablation zone size, and correlation of postablation MRI and pathologic findings. AJNR Am J Neuroradiol 2017;38:1653–59 doi:10.3174/ajnr.A5228 pmid:28572150
    Abstract/FREE Full Text
  21. 21.↵
    1. Gage AA,
    2. Baust J
    . Mechanisms of tissue injury in cryosurgery. Cryobiology 1998;37:171–86 doi:10.1006/cryo.1998.2115 pmid:9787063
    CrossRefPubMed
  22. 22.↵
    1. Collins GH,
    2. West NR,
    3. Parmely JD, et al
    . The histopathology of freezing injury to the rat spinal cord: a light microscope study, I: early degenerative changes. J Neuropathol Exp Neurol 1986;45:721–41 doi:10.1097/00005072-198611000-00009 pmid:3772400
    CrossRefPubMed
  23. 23.↵
    1. Jia J,
    2. Pollock M
    . The pathogenesis of non-freezing cold nerve injury: observations in the rat. Brain 1997;120:631–46 doi:10.1093/brain/120.4.631 pmid:9153125
    CrossRefPubMed
  24. 24.↵
    1. Hansebout RR,
    2. Lamont RN,
    3. Kamath MV
    . The effects of local cooling on canine spinal cord blood flow. Can J Neurol Sci 1985;12:83–87 doi:10.1017/S0317167100046758 pmid:4016595
    CrossRefPubMed
  25. 25.↵
    1. Romero-Sierra C,
    2. Hansebout R,
    3. Sierhuis A, et al
    . A new method for localised spinal-cord cooling. Med Biol Eng 1974;12:188–93 doi:10.1017/s0317167100046758 pmid:4016595
    CrossRefPubMed
  26. 26.↵
    1. Ito Z,
    2. Matsuyama Y,
    3. Ando M, et al
    . What is the best multimodality combination for intraoperative spinal cord monitoring of motor function? A multicenter study by the monitoring committee of the Japanese Society for Spine Surgery and Related Research. Global Spine J 2016;6:234–41 doi:10.1055/s-0035-1559582 pmid:27099814
    CrossRefPubMed
  27. 27.↵
    1. Brekke MF,
    2. la Cour K,
    3. Brandt Å, et al
    . The association between ADL ability and quality of life among people with advanced cancer. Occup Ther Int 2019;2019:2629673 doi:10.1155/2019/2629673 pmid:31531007
    CrossRefPubMed
  28. 28.↵
    1. Nakatsuka A,
    2. Yamakado K,
    3. Takaki H, et al
    . Percutaneous radiofrequency ablation of painful spinal tumors adjacent to the spinal cord with real-time monitoring of spinal canal temperature: a prospective study. Cardiovasc Intervent Radiol 2009;32:70–75 doi:10.1007/s00270-008-9390-9 pmid:18661176
    CrossRefPubMed
  29. 29.↵
    1. Buy X,
    2. Tok CH,
    3. Szwarc D, et al
    . Thermal protection during percutaneous thermal ablation procedures: interest of carbon dioxide dissection and temperature monitoring. Cardiovasc Intervent Radiol 2009;32:529–34 doi:10.1007/s00270-009-9524-8 pmid:19219496
    CrossRefPubMed
  30. 30.↵
    1. Kastler A,
    2. Krainik A,
    3. Sakhri L, et al
    . Feasibility of real-time intraprocedural temperature control during bone metastasis thermal microwave ablation: a bicentric retrospective study. J Vasc Interv Radiol 2017;28:366–71 doi:10.1016/j.jvir.2016.09.030 pmid:28007329
    CrossRefPubMed
  31. 31.↵
    1. Bischof J,
    2. Christov K,
    3. Rubinsky B
    . A morphological study of cooling rate response in normal and neoplastic human liver tissue: cryosurgical implications. Cryobiology 1993;30:482–92 doi:10.1006/cryo.1993.1049 pmid:8252916
    CrossRefPubMed
  32. 32.↵
    1. Gage AA
    . What temperature is lethal for cells? J Dermatol Surg Oncol 1979;5:459–60, 464 doi:10.1111/j.1524-4725.1979.tb00695.x pmid:110858
    CrossRefPubMed
  • Received September 16, 2023.
  • Accepted after revision December 18, 2023.
  • © 2024 by American Journal of Neuroradiology
PreviousNext
Back to top
Advertisement
Print
Download PDF
Email Article

Thank you for your interest in spreading the word on American Journal of Neuroradiology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Evaluation of Conditions for the Development of Cryogenic Spinal Cord Injury Using a Canine Model: An Experimental Study on the Safety of Cryoablation for Metastatic Spinal Tumors
(Your Name) has sent you a message from American Journal of Neuroradiology
(Your Name) thought you would like to see the American Journal of Neuroradiology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Cite this article
Motoya Kobayashi, Satoshi Kato, Satoru Demura, Noriaki Yokogawa, Akira Yokka, Yusuke Nakade, Ryohei Annen, Toshifumi Gabata, Hiroyuki Tsuchiya
Evaluation of Conditions for the Development of Cryogenic Spinal Cord Injury Using a Canine Model: An Experimental Study on the Safety of Cryoablation for Metastatic Spinal Tumors
American Journal of Neuroradiology Mar 2024, DOI: 10.3174/ajnr.A8151

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
0 Responses
Respond to this article
Share
Bookmark this article
Evaluation of Conditions for the Development of Cryogenic Spinal Cord Injury Using a Canine Model: An Experimental Study on the Safety of Cryoablation for Metastatic Spinal Tumors
Motoya Kobayashi, Satoshi Kato, Satoru Demura, Noriaki Yokogawa, Akira Yokka, Yusuke Nakade, Ryohei Annen, Toshifumi Gabata, Hiroyuki Tsuchiya
American Journal of Neuroradiology Mar 2024, DOI: 10.3174/ajnr.A8151
del.icio.us logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Purchase

Jump to section

  • Article
    • Abstract
    • ABBREVIATIONS:
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • CONCLUSIONS
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Supplemental
  • Info & Metrics
  • Responses
  • References
  • PDF

Related Articles

  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Crossref
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

More in this TOC Section

  • Factors Associated with Major Re-Recanalization following Second Coiling for Recanalized Aneurysms: A Multicenter Experience over 20 Years during Long-Term Follow-up
  • A Key Factor Shapes LS-DAVFs EVT Outcome
  • Optimizing Voxel Size in 3D Rotational Angiography
Show more NEUROINTERVENTION

Similar Articles

Advertisement

Indexed Content

  • Current Issue
  • Accepted Manuscripts
  • Article Preview
  • Past Issues
  • Editorials
  • Editor's Choice
  • Fellows' Journal Club
  • Letters to the Editor
  • Video Articles

Cases

  • Case Collection
  • Archive - Case of the Week
  • Archive - Case of the Month
  • Archive - Classic Case

More from AJNR

  • Trainee Corner
  • Imaging Protocols
  • MRI Safety Corner

Multimedia

  • AJNR Podcasts
  • AJNR Scantastics

Resources

  • Turnaround Time
  • Submit a Manuscript
  • Submit a Video Article
  • Submit an eLetter to the Editor/Response
  • Manuscript Submission Guidelines
  • Statistical Tips
  • Fast Publishing of Accepted Manuscripts
  • Graphical Abstract Preparation
  • Imaging Protocol Submission
  • Evidence-Based Medicine Level Guide
  • Publishing Checklists
  • Author Policies
  • Become a Reviewer/Academy of Reviewers
  • News and Updates

About Us

  • About AJNR
  • Editorial Board
  • Editorial Board Alumni
  • Alerts
  • Permissions
  • Not an AJNR Subscriber? Join Now
  • Advertise with Us
  • Librarian Resources
  • Feedback
  • Terms and Conditions
  • AJNR Editorial Board Alumni

American Society of Neuroradiology

  • Not an ASNR Member? Join Now

© 2025 by the American Society of Neuroradiology All rights, including for text and data mining, AI training, and similar technologies, are reserved.
Print ISSN: 0195-6108 Online ISSN: 1936-959X

Powered by HighWire